AstraZeneca PLC
Market Cap
280B
Short interest (May 15)
0.1%
Net Short (Jun 03 ): 0.0%
Borrow Fee
0.30%
↓ 2.3%
Available Shares
2M
↑ 2.4%
Price Chart
Company Overview
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.